BOSTON SCIENTIFIC CORPORATION Tax Adjustments, Settlements, and Unusual Provisions
BOSTON SCIENTIFIC CORPORATION (BSX) reported Tax Adjustments, Settlements, and Unusual Provisions of $44.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2025-02-18
- BOSTON SCIENTIFIC CORPORATION tax adjustments, settlements, and unusual provisions for the quarter ending 2021-09-30 was $91.00M, a 0.00% change year-over-year.
- BOSTON SCIENTIFIC CORPORATION tax adjustments, settlements, and unusual provisions for the quarter ending 2020-12-31 was $62.00M.
- BOSTON SCIENTIFIC CORPORATION tax adjustments, settlements, and unusual provisions for the quarter ending 2020-09-30 was $91.00M.
- BOSTON SCIENTIFIC CORPORATION tax adjustments, settlements, and unusual provisions for the quarter ending 2018-12-31 was $90.00M.
- BOSTON SCIENTIFIC CORPORATION tax adjustments, settlements, and unusual provisions for fiscal 2023 was $44.00M, a 175.00% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION tax adjustments, settlements, and unusual provisions for fiscal 2022 was $16.00M, a 74.19% decline from fiscal 2021.
- BOSTON SCIENTIFIC CORPORATION tax adjustments, settlements, and unusual provisions for fiscal 2021 was $62.00M, a 0.00% change from fiscal 2020.
- BOSTON SCIENTIFIC CORPORATION tax adjustments, settlements, and unusual provisions for fiscal 2020 was $62.00M.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions 3 month | Tax Adjustments, Settlements, and Unusual Provisions 6 month | Tax Adjustments, Settlements, and Unusual Provisions 9 month | Tax Adjustments, Settlements, and Unusual Provisions 12 month |
|---|---|---|---|---|
| 2023-12-31 | $44.00M 10-K · filed 2025-02-18 | |||
| 2022-12-31 | $16.00M 10-K · filed 2024-02-20 | |||
| 2021-12-31 | $62.00M 10-K · filed 2023-02-23 | |||
| 2021-09-30 | $91.00M 10-K · filed 2023-02-23 | |||
| 2020-12-31 | $62.00M 10-K · filed 2021-02-23 | $153.00M derived: sum of 2 quarters · filed 2022-02-23 | $62.00M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $91.00M 10-K · filed 2022-02-23 | |||
| 2018-12-31 | $90.00M 10-K · filed 2020-02-25 | $90.00M derived: sum of 2 quarters · filed 2020-02-25 | $250.00M 10-K · filed 2021-02-23 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $250.00M 10-Q · filed 2018-10-29 | ||
| 2018-06-30 | $250.00M 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |